Search:
Tokushima University > Graduate School of Biomedical Sciences > 医学域 > Medical Science > Internal Medicine > Department of Respiratory Medicine and Rheumatology >
Tokushima University > University Hospital > Clinical Division > Department of Internal Medicine > Respiratory and Rheumatology Medicine >
Tokushima University > Faculty of Medicine > School of Medicine > Course of Bioregulation and Medical Oncology > Respiratory Medicine and Rheumatology >
(CSV files for researchmap) [PDF manual]

Research Activity

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1. Hiroyasu Okazaki, Seidai Satou, Kazuya Koyama, Shun Morizumi, Shuichi Abe, Momoyo Azuma, Yajuan Chen, Hisatsugu Goto, Yoshinori Aono, Hirohisa Ogawa, Kozo Kagawa, Haruka Nishimura, Hiroshi Kawano, Yuko Toyoda, Hisanori Uehara, Hiroyuki Kouji and Yasuhiko Nishioka :
The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.,
Experimental Lung Research, Vol.45, No.7, 188-199, 2019.
(Tokushima University Institutional Repository: 113984,   DOI: 10.1080/01902148.2019.1638466,   PubMed: 31298961,   Elsevier: Scopus)

Proceeding of Domestic Conference:

1. Mayo Kondou, Hiroki Bandoh, Kozo Kagawa, 西村 春佳, 小山 壱也, Seidai Satou, Yuko Toyoda, Masahiko Azuma, Hirohisa Ogawa, Hisatsugu Goto and Yasuhiko Nishioka :
リゾフォスファチジン酸を標的にしたアレルギー性気道炎症制御についての検討,
第257回徳島医学会学術集会, Aug. 2018.
2. Atsushi Mitsuhashi, Kozo Kagawa, Hiroto Yoneda, Atsuro Saijo, Makoto Tobiume, Hirokazu Ogino, Mayo Kondou, Naoki Takahashi, Hiroshi Nokihara, Hisatsugu Goto and Yasuhiko Nishioka :
当科における免疫チェックポイント阻害薬による薬剤性間質性肺疾患の検討,
第59回日本呼吸器学会中国・四国地方会/第57回日本肺癌学会中国・四国支部学術集会, Jul. 2018.
3. 坂東 紀子, Yuko Toyoda, Hiroshi Kawano, Seidai Satou, 小山 壱也, 西村 春佳, Kozo Kagawa, Nobuhito Naitoh, Masahiko Azuma and Yasuhiko Nishioka :
当科で経験した抗MDA5抗体陽性皮膚筋炎合併間質性肺炎の臨床像の検討,
第59回日本呼吸器学会中国・四国地方会, Jul. 2018.
4. Nobuhito Naitoh, 森田 優, Kozo Kagawa, Mayo Kondou, 西村 春佳, Hiroshi Kawano, Yuko Toyoda, Jun Kishi, Hisatsugu Goto and Yasuhiko Nishioka :
Tocilizumab が有効であった重症成人発症スティル病の1例,
第118回日本内科学会四国地方会, Jun. 2018.